Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Multiple Myeloma 125Recurrence 12Neoplasms 8Immunoglobulin Light-chain Amyloidosis 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Neoplasms, Plasma Cell 5Smoldering Multiple Myeloma 4Lymphoma 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Lymphoma, Non-Hodgkin 3Leukemia, Lymphocytic, Chronic, B-Cell 3Plasmacytoma 2Plasmablastic Lymphoma 2Neoplasm, Residual 2Myelodysplastic Syndromes 2Hodgkin Disease 2Hematologic Neoplasms 2Amyloidosis 2Acute Kidney Injury 2Triple Negative Breast Neoplasms 1Proteostasis Deficiencies 1Primary Myelofibrosis 1Paraproteinemias 1Non-small Cell Lung Cancer With STK11/LKB1 Mutation 1Microsatellite Unstable Colorectal Cancer 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Plasma Cell 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

daratumumab 1Watchful Waiting 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemangioma, Cavernous, Central Nervous System × daratumumab × 1 year × Clear all
NCT07026604 2025-06-18

CCM-DS01

Beijing Tiantan Hospital

Phase EARLY_PHASE1 Not yet recruiting
10 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon âš¡